Compounds of the class of 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-carboxamides, their 5-oxides and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties and are active ingredients for therapeutic compositions. In particular, these new compounds have an anti-convulsive and anti-aggressive action and potentiate the action of anaesthetics. Specific embodiments are N,N-dimethyl-6-phenyl-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-c arboxamide, 6-phenyl-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-carboxamide, N,N-dimethyl-6-(o-chlorophenyl-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiaz epine-1-carboxamide and 6-(o-chlorophenyl)-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-carb oxamide.
6-苯基-4H-s-三唑并[4,3-a][1,4]苯并二氮平-1-羧
酰胺类化合物、它们的5-氧化物及其药学上可接受的酸盐加合物具有有价值的药理学特性,并且是治疗组合物的活性成分。特别是,这些新化合物具有抗惊厥和抗攻击作用,并增强
麻醉剂的作用。具体实施例包括N,N-二甲基-6-苯基-8-
氯-4H-s-三唑并[4,3-a][1,4]苯并二氮平-1-羧酰胺、6-苯基-8-
氯-4H-s-三唑并[4,3-a][1,4]苯并二氮平-1-羧酰胺、N,N-二甲基-6-(o-
氯苯基)-8-
氯-4H-s-三唑并[4,3-a][1,4]苯并二氮平-1-羧酰胺和6-(o-
氯苯基)-8-
氯-4H-s-三唑并[4,3-a][1,4]苯并二氮平-1-羧酰胺。